#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA663133	B	Binding energy to Streptococcus faecium dihydrofolate reductase	Enterococcus faecium	68		single protein format	Scientific Literature
2.	ALA663137	B	Binding energy against Streptococcus faecium dihydrofolate reductase	Enterococcus faecium	68		single protein format	Scientific Literature
3.	ALA666235	B	The concentration required to inhibit dihydrofolate reductase in rat liver		107		tissue-based format	Scientific Literature
4.	ALA666236	B	Inhibitory activity against dihydrofolate reductase of rat liver		39		assay format	Scientific Literature
5.	ALA666238	B	Concentration required for inhibition of rat liver dihydrofolate reductase (DHFR)		103		assay format	Scientific Literature
6.	ALA3257257	F	Antimalarial activity against trophozoite-induced Plasmodium berghei infected in sc dosed mouse assessed as minimum curative dose	Plasmodium berghei	36		organism-based format	Scientific Literature
7.	ALA3257264	F	Antimalarial activity against trophozoite-induced Plasmodium berghei infected in mouse assessed as change in mean survival time at 10 mg/kg, sc single dose after 72 hrs of infection	Plasmodium berghei	27		organism-based format	Scientific Literature
8.	ALA3257265	F	Antimalarial activity against trophozoite-induced Plasmodium berghei infected in mouse assessed as change in mean survival time at 5 mg/kg, sc single dose after 72 hrs of infection	Plasmodium berghei	17		organism-based format	Scientific Literature
9.	ALA3257266	F	Antimalarial activity against trophozoite-induced Plasmodium berghei infected in mouse assessed as change in mean survival time at 2.5 mg/kg, sc single dose after 72 hrs of infection	Plasmodium berghei	18		organism-based format	Scientific Literature
10.	ALA3257267	F	Antimalarial activity against trophozoite-induced Plasmodium berghei infected in mouse assessed as change in mean survival time at 1.25 mg/kg, sc single dose after 72 hrs of infection	Plasmodium berghei	15		organism-based format	Scientific Literature
11.	ALA3259106	F	Antimalarial activity against Plasmodium gallinaceum infected in mouse assessed as quinine equivalent to dose required to suppress parasitemia by 75% compound treated through gavage for 3 days	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
12.	ALA3259108	F	Antimalarial activity against Plasmodium gallinaceum parent strain infected in mouse assessed as dose required to suppress parasitemia by 90% compound treated through gavage for 3 days	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
13.	ALA3252246	F	Antimalarial activity against chloroquine-resistant Plasmodium gallinaceum infected in mouse assessed as dose required to suppress parasitemia by 90% compound treated through gavage for 3 days	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
14.	ALA3252248	F	Antimalarial activity against cycloguanil-resistant Plasmodium gallinaceum infected in mouse assessed as dose required to suppress parasitemia by 90% compound treated through gavage for 3 days	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
15.	ALA3252250	F	Antimalarial activity against DDS-resistant Plasmodium gallinaceum infected in mouse assessed as dose required to suppress parasitemia by 90% compound treated through gavage for 3 days	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
16.	ALA3252252	F	Antimalarial activity against chloroquine-resistant Plasmodium gallinaceum infected in mouse assessed as dose required to suppress parasitemia by 90% compound treated through gavage for 3 days relative to parent strain	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
17.	ALA3252254	F	Antimalarial activity against cycloguanil-resistant Plasmodium gallinaceum infected in mouse assessed as dose required to suppress parasitemia by 90% compound treated through gavage for 3 days relative to parent strain	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
18.	ALA3253631	F	Antimalarial activity against DDS-resistant Plasmodium gallinaceum infected in mouse assessed as dose required to suppress parasitemia by 90% compound treated through gavage for 3 days relative to parent strain	Plasmodium gallinaceum	8		organism-based format	Scientific Literature
19.	ALA3253632	F	Antimalarial activity against chloroquine-sensitive, pyrimethamine-resistant Plasmodium falciparum Malayan Camp CH/Q infected in Aotus monkey assessed as dose required to >50% cures compound treated for 7 days	Plasmodium falciparum	9		organism-based format	Scientific Literature
20.	ALA3253633	F	Antimalarial activity against chloroquine-resistant, pyrimethamine-sensitive Plasmodium falciparum Vietnam Oak Knoll in Aotus monkey assessed as dose required to >50% cures compound treated for 7 days	Plasmodium falciparum	10		organism-based format	Scientific Literature